July 12, 2024:

Mark Burkard, MD, PhD, has been named director of Holden Comprehensive Cancer Center at the University of Iowa, and will begin his new role on October 1, pending approval from the Iowa Board of Regents. He will also begin as professor in the Department of Internal Medicine in the Division of Hematology, Oncology, and Blood Marrow Transplantation in the Carver College of Medicine.

Burkard currently serves as the Mary and Rob Gooze Chair in Metastatic Breast Cancer and professor in the Division of Hematology, Medical Oncology, and Palliative Care in the University of Wisconsin (UW)–Madison’s Department of Internal Medicine. Burkard specializes in precision oncology and the treatment of breast cancer. He serves as the associate director of Genomics and Precision Medicine within the UW Carbine Cancer Center and director of the UW-Madison Medical Scientist Training Program.

Dr. Burkard has been active in the consortium for many years as a member of the breast cancer clinical trial working group and, most recently, as the Big Ten CRC co-chair of the basket trials working group.

Read more: https://cancer.uiowa.edu/news/burkard-named-director-ui-health-care-holden-comprehensive-cancer-center

About the Big Ten Cancer Research Consortium: The Big Ten Cancer Research Consortium was created in 2013 to transform the conduct of cancer research through collaborative clinical trials and observational studies that seek to improve the lives of cancer patients in the diverse communities we serve by leveraging the scientific and clinical expertise of Big Ten universities. The Big Ten Cancer Research Consortium creates a unique team research culture to drive science rapidly from ideas to treatment and prevention. Within this innovative environment, today’s research leaders collaborate with and mentor the research leaders of tomorrow. Since its founding, the Big Ten CRC has activated nearly 40 clinical trials across a wide range of cancer types, more than 1,000 participants have enrolled in Big Ten CRC studies, and more than 500 researchers have joined Big Ten CRC Clinical Trial Working Groups.

About the Big Ten Conference: The Big Ten Conference is an association of world-class universities whose member institutions share a common mission of research, graduate, professional and undergraduate teaching and public service. Founded in 1896, the Big Ten has sustained a comprehensive set of shared practices and policies that enforce the priority of academics in the lives of students competing in intercollegiate athletics and emphasize the values of integrity, fairness and competitiveness. The broad-based programs of the 18 Big Ten institutions provide direct financial support for more than 11,000 participation opportunities on 350 teams in 42 different sports. The Big Ten sponsors 28 official conference sports, 14 for men and 14 for women. For more information, visit www.bigten.org.